Search Results - "Lu, Hongfu"
-
1
Interface defect chemistry enables dendrite-free lithium metal anodes
Published in Chemical engineering journal (Lausanne, Switzerland : 1996) (01-06-2022)“…•An artificial protective layer with interface defects is proposed;•Interface defect chemistry promotes the lithium ions diffusion kinetics;•Interface oxygen…”
Get full text
Journal Article -
2
Mild and Regioselective N‑Alkylation of 2‑Pyridones in Water
Published in Organic letters (17-07-2015)“…A mild and regioselective N-alkylation reaction of 2-pyridones in water has been developed. Tween 20 (2% w/w) was added to create a micellar system for…”
Get full text
Journal Article -
3
Efficient and C2-selective arylation of indoles, benzofurans, and benzothiophenes with iodobenzenes in water at room temperature
Published in Tetrahedron (06-05-2015)“…A mild, efficient, and C2-selective palladium-catalyzed arylation reaction of indoles, benzofurans, and benzothiophenes with iodobenzenes at room temperature…”
Get full text
Journal Article -
4
Discovery of 1(2H)-phthalazinone and 1(2H)-isoquinolinone derivatives as potent hematopoietic progenitor kinase 1 (HPK1) inhibitors
Published in European journal of medicinal chemistry (05-12-2024)“…Although immune checkpoint inhibitors (ICIs) have been a revelation for treating several cancers, an unmet need remains to broaden ICI therapeutic scope and…”
Get full text
Journal Article -
5
Constructing an inorganic/organic mixed protective film for low-cost fabrication of stable lithium metal anode
Published in Journal of alloys and compounds (25-03-2020)“…Lithium metal has been recognized as the most promising anode for next generation of ultra-high energy density batteries. However, lithium dendrites have…”
Get full text
Journal Article -
6
Discovery of a Novel Macrocyclic Noncovalent CDK7 Inhibitor for Cancer Therapy
Published in Journal of medicinal chemistry (09-11-2024)“…Cyclin-dependent kinase 7 (CDK7) is a key regulator of the cell cycle and transcription, making it a promising target for cancer therapy. Although current CDK7…”
Get full text
Journal Article -
7
Design, Synthesis, and Biological Evaluation of a Series of Spiro Analogues as Novel HPK1 Inhibitors
Published in ACS medicinal chemistry letters (14-11-2024)“…Hematopoietic progenitor kinase 1 (HPK1) negatively affects T cell activation and proliferation and is a promising target for immunotherapy. Although HPK1…”
Get full text
Journal Article -
8
Chiral 2-aminopyrimidin-4(1H)-one derivative as the novel bifunctional organocatalyst: enantioselective Aldol reaction of isatins with ketones
Published in Tetrahedron (06-05-2015)“…Chiral 2-aminopyrimidin-4(1H)-one derivative 2 was discovered as a novel bifunctional organocatalyst for the asymmetric Aldol reaction of isatins with ketones…”
Get full text
Journal Article -
9
Abstract 1855: Targeting DGKA for immuno-oncology therapy: ISM4312A, a novel DGKA inhibitor with robust anti-tumor activity
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Diacylglycerol kinases (DGKs), a family of isozymes that phosphorylate the membrane lipid, diacylglycerol (DAG), to phosphatidic acid (PA), are…”
Get full text
Journal Article -
10
Abstract 3967: ISM9182A, a novel HPK1 inhibitor, exhibits immune modulatory activity and robust monotherapy anti-tumor effects in preclinical studies
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Abstract The hematopoietic progenitor kinase 1 (HPK1 or MAP4K1) is a member of the Ste20 serine/threonine kinase super family that negatively regulates immune…”
Get full text
Journal Article -
11
Discovery of Novel 1‑Cyclopentenyl-3-phenylureas as Selective, Brain Penetrant, and Orally Bioavailable CXCR2 Antagonists
Published in Journal of medicinal chemistry (22-03-2018)“…CXCR2 has emerged as a therapeutic target for not only peripheral inflammatory diseases but also neurological abnormalities in the central nervous system…”
Get full text
Journal Article -
12
Abstract 4989: Discovery and evaluation of ISM6466A, a novel covalent CDK12 inhibitor for the treatment of cancer
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Cyclin-dependent kinase 12 (CDK12) belongs to the cyclin-dependent kinase (CDK) family of serine/threonine protein kinases. The CDK12/cyclin K complex…”
Get full text
Journal Article -
13
2-Aminopyrimidin-4(1H)-one as the novel bioisostere of urea: Discovery of novel and potent CXCR2 antagonists
Published in Bioorganic & medicinal chemistry letters (01-12-2014)“…[Display omitted] 2-Aminopyrimidin-4(1H)-one was proposed as the novel bioisostere of urea. Bioisosteric replacement of the reported urea series of the CXCR2…”
Get full text
Journal Article -
14
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders
Published in ACS medicinal chemistry letters (14-04-2016)“…Structure–activity relationship exploration of the historical biarylurea series led to the identification of novel CNS penetrant CXCR2 antagonists with…”
Get full text
Journal Article